Eledon Pharmaceuticals, Inc. (ELDN) income statement
ELDNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.78−0.12 (-6.32%)
Close on Nov 20, 2026Market cap $144.65MP/E –Yield –
Eledon Pharmaceuticals, Inc. financial ratios
See a number that looks wrong?